Interim analysis (IA) of OPTIC: A dose-ranging study of three ponatinib (PON) starting doses.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.7502
Abstract: 7502Background: In PACE (NCT01207440) heavily pretreated patients (pts) with chronic-phase CML (CP-CML) had deep, lasting responses to PON; long-term follow-up showed increasing rates of arterial o... read more here.
Keywords: dose ranging; analysis optic; interim analysis; ranging study ... See more keywords
Dose-ranging study of an orlistat tablet formulation.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp203191
Abstract: OBJECTIVE Examine inhibition of dietary fat absorption with orlistat tablets (24, 36, 48, 72, and 144 mg) vs. 60-mg orlistat capsule. MATERIALS AND METHODS 83 overweight/obese subjects randomized to 1 of 6 open-label treatments. Pre- vs.… read more here.
Keywords: fecal fat; dose ranging; orlistat tablet; study orlistat ... See more keywords